🇸🇬 Arcapta Neohaler in Singapore

Arcapta Neohaler (INDACATEROL) regulatory status in Singapore.

Marketing authorisation

HSA

  • Status: likely_approved

Arcapta Neohaler in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Respiratory approved in Singapore

Frequently asked questions

Is Arcapta Neohaler approved in Singapore?

Yes. HSA has authorised it.

Who is the marketing authorisation holder for Arcapta Neohaler in Singapore?

Novartis is the originator. The local marketing authorisation holder may differ — check the official source linked above.